Status:

COMPLETED

Stress, Hypothalamic-pituitary-adrenal (HPA) Dysfunction, and Relapse in Alcoholism

Lead Sponsor:

University of Texas Southwestern Medical Center

Collaborating Sponsors:

Dallas VA Medical Center

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Conditions:

Alcohol Dependence

Eligibility:

MALE

18-60 years

Brief Summary

This proposal is part of the INIA Stress Consortium. This study will 1. explore the contributions of lifetime trauma, recent stress, and alcohol use on stress-hormone axis disruption in treatment see...

Detailed Description

The hypothalamic-pituitary-adrenal (HPA) system is suggested as a key biologic link in stress-induced relapse. The HPA axis provides a regulatory feedback network between the brain and the body's beha...

Eligibility Criteria

Inclusion

  • Diagnosis of alcohol dependence

Exclusion

  • Medical or psychiatric disorders that may effect stress-hormone axis functioning.
  • Medications that may effect stress-hormone axis functioning.
  • English speaking.

Key Trial Info

Start Date :

August 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 1 2012

Estimated Enrollment :

75 Patients enrolled

Trial Details

Trial ID

NCT00744588

Start Date

August 1 2007

End Date

March 1 2012

Last Update

January 3 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UT Southwestern Medical Center at Dallas

Dallas, Texas, United States, 75390-8564